Skip to content
Dx

ICD-10-CM 2027 diagnosis code

D48.113Desmoid tumor of abdominal wall

✓ Billable / specific

D48.113 is a valid, billable ICD-10-CM code for desmoid tumor of abdominal wall. It can be reported on claims for dates of service from October 1, 2026 – September 30, 2027.

Code last changed in FY2024 (effective October 1, 2023). Source: official FY2027 ICD-10-CM release from CDC/NCHS and CMS. Page updated September 29, 2026. About our data

About D48.113

D48.113 is the ICD-10-CM diagnosis code for Desmoid tumor of abdominal wall. It belongs to category D48 (neoplasm of uncertain behavior of other and unspecified sites), block D37-D48 (neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes) and chapter 2 (neoplasms). It is billable, so it can be reported on its own for dates of service from October 1, 2026 through September 30, 2027.

Within D48.11 (Desmoid tumor), D48.113 is specifically for Desmoid tumor of abdominal wall. Related codes cover of head and neck (D48.110), of chest wall (D48.111), intrathoracic (D48.112), intraabdominal (D48.114), of upper extremity and shoulder girdle (D48.115), of lower extremity and pelvic girdle (D48.116), of back (D48.117), of other site (D48.118) and 1 more.

It is not a CC or MCC, so as a secondary diagnosis it doesn't change the MS-DRG severity level.

In MS-DRG v44.0, it is part of the grouping logic for DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC, relative weight 1.4908), DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC, relative weight 0.9783) and DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC, relative weight 0.7378), in MDC 08 (Diseases and Disorders of the Musculoskeletal System and Connective Tissue), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.

It was added in FY2024, effective October 1, 2023.

Notes that apply from higher levels

Instructions written at a parent level also apply to D48.113.

› From D48.1 Neoplasm of uncertain behavior of connective and other soft tissue
Excludes1
  • neoplasm of uncertain behavior of articular cartilage (D48.0)
  • neoplasm of uncertain behavior of cartilage of larynx (D38.0)
  • neoplasm of uncertain behavior of cartilage of nose (D38.5)
  • neoplasm of uncertain behavior of connective tissue of breast (D48.6-)
› From D48 Neoplasm of uncertain behavior of other and unspecified sites
Excludes1
  • neurofibromatosis (nonmalignant) (Q85.0-)

Broader instructions also apply from D37-D48 Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes and Chapter 2: Neoplasms.

Alphabetic index entries

1 entries

Terms in the official ICD-10-CM index that lead to D48.113.

MS-DRG v44.0 grouping

All DRGs →

Inpatient MS-DRGs this diagnosis can group to, as the principal or a secondary diagnosis, depending on the rest of the claim.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2024 (effective 10/1/2023): Added
  • No changes since FY2024.

Common questions about D48.113

Is D48.113 billable?

Yes. D48.113 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).

Can D48.113 be used as a principal diagnosis?

Yes. The Medicare Code Editor doesn't restrict D48.113 as a principal diagnosis.

Is D48.113 a CC or MCC?

No. D48.113 is neither a CC nor an MCC under MS-DRG v44.0.

What DRG does D48.113 group to?

D48.113 is used in the MS-DRG v44.0 logic for MS-DRG 564 (Other Musculoskeletal System and Connective Tissue Diagnoses with MCC), MS-DRG 565 (Other Musculoskeletal System and Connective Tissue Diagnoses with CC) and MS-DRG 566 (Other Musculoskeletal System and Connective Tissue Diagnoses without CC/MCC). Which one applies depends on whether it is the principal diagnosis and on the rest of the claim.